"An anonymous reader quotes a report from Scientific American:
The research is still developing, but the findings hint that the drug could one day form the basis for a powerful addition to current cancer therapies.
Not everyone responds equally well to the drug, however, and for some people it can be downright dangerous.
Investigators are thus trying to develop genetic tests to determine who is most likely to benefit from long-term use of aspirin..."
No comments:
Post a Comment